Product Introduction:
AlphaVog GM2 Tablet is a combination medication that contains three active ingredients: Glimepiride (2mg), Metformin (500mg), and Voglibose (0.3mg). It is prescribed for the management of type 2 diabetes mellitus. Glimepiride belongs to the sulfonylurea class, Metformin is a biguanide, and Voglibose is an alpha-glucosidase inhibitor. Each of these components works through different mechanisms to help control blood sugar levels in patients with diabetes.
AlphaVog GM2 Tablet should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
The most common side effect of AlphaVog GM2 Tablet is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking and know how to deal with it. To prevent this, it’s important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache, edema (swelling), blurred vision, bone fracture, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.
Benefits:
- Comprehensive Blood Sugar Control: The combination of Glimepiride, Metformin, and Voglibose provides comprehensive control over blood sugar levels by targeting different aspects of glucose metabolism.
- Improved Insulin Sensitivity: Metformin helps improve insulin sensitivity in peripheral tissues, making cells more responsive to insulin’s effects.
- Reduced Glucose Absorption: Voglibose slows down carbohydrate digestion and absorption in the intestines, thereby reducing postprandial blood sugar spikes.
- Stimulated Insulin Release: Glimepiride stimulates the release of insulin from pancreatic beta cells, helping to lower blood sugar levels.
Side Effects:
Common side effects of AlphaVog GM2 Tablet may include:
- Gastrointestinal Disturbances: These may include nausea, vomiting, diarrhea, or abdominal discomfort, particularly during the initial stages of treatment.
- Hypoglycemia: As Glimepiride stimulates insulin release, hypoglycemia (low blood sugar) can occur, especially if the medication is taken without sufficient food intake or in combination with other antidiabetic medications.
- Lactic Acidosis: While rare, Metformin can cause a serious condition called lactic acidosis, characterized by symptoms such as muscle pain, weakness, difficulty breathing, and abdominal discomfort.
- Flatulence: Voglibose can cause increased gas production and flatulence due to undigested carbohydrates reaching the colon.
Usage Guidelines:
- Dosage: The dosage of AlphaVog GM2 Tablet may vary depending on the patient’s condition and response to treatment. It is typically taken orally, usually with meals.
- Administration: Swallow the tablet whole with a glass of water. It is important to follow the prescribed dosage and timing as instructed by the healthcare provider.
- Dietary Considerations: Patients should follow a balanced diet and meal plan as recommended by their healthcare provider while taking AlphaVog GM2 Tablet to help optimize blood sugar control.
- Monitoring: Regular monitoring of blood glucose levels, as well as kidney and liver function tests, may be required during treatment with this medication.
Drug Interactions:
- Other Antidiabetic Medications: Concurrent use of AlphaVog GM2 Tablet with other antidiabetic medications, such as insulin or other oral hypoglycemic agents, may increase the risk of hypoglycemia.
- Alcohol: Alcohol consumption may potentiate the hypoglycemic effects of Glimepiride and increase the risk of lactic acidosis with Metformin.
- Certain Medications: Some medications, such as certain antibiotics, may interact with Metformin and increase the risk of lactic acidosis.
- Contrast Agents: Metformin should be temporarily discontinued before using contrast agents for certain medical procedures to reduce the risk of lactic acidosis.
Before starting AlphaVog GM2 Tablet, patients should inform their healthcare provider about all medications, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions. Adhering to the prescribed dosage and dietary recommendations is crucial for optimal efficacy and safety. Any concerns or adverse effects should be promptly reported to the healthcare provider.
SAFETY ADVICE
Alcohol
Pregnancy
Breast feeding
Driving
Kidney
Use of AlphaVog GM2 Tablet is, however, not recommended in patients with severe kidney disease.
Liver
AlphaVog GM2 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
| Weight | 0.5 kg |
|---|---|
| Dimensions | 10 × 10 × 10 cm |
